150 articles, page 9 of 13
Newest first
Mounjaro and Zepbound are both tirzepatide. The difference is the name on the box, the FDA approval behind it, and whether your insurance will pay for it.
By Arbor Health Team
When the FDA approved the Wegovy pill on December 22, 2025, it marked a turning point in obesity medicine.
By Arbor Health Team
For more than two decades, Medicare has been legally prohibited from covering medications prescribed for weight loss.
By Arbor Health Team
If you're over 60 and considering tirzepatide, you've likely already heard the headlines of dramatic weight loss and cardiovascular protection.
By Arbor Health Team
If you've ever spent an entire meeting mentally replaying what's in your refrigerator, or found yourself negotiating with a drive-through at 10 p.m.
By Arbor Health Team
If you've been getting compounded tirzepatide, you've probably noticed the ground shifting beneath your feet.
By Arbor Health Team
You can lose 20 percent of your body weight on tirzepatide without lifting a single dumbbell.
By Arbor Health Team
Every conversation about GLP-1 medications eventually arrives at the same uncomfortable question: how long do I have to stay on this? The marketing frames semaglutide and tirzepatide as transformational, and the clinical data backs that up.
By Arbor Health Team
Tirzepatide, the active ingredient in Mounjaro and Zepbound, has become one of the most prescribed medications in the country.
By Arbor Health Team
If you have been taking semaglutide, whether as Ozempic for type 2 diabetes or Wegovy for weight loss, and the results have slowed, stopped, or never quite reached where you wanted them, you are far from alone.
By Arbor Health Team
Most people who have heard of tirzepatide know it as Mounjaro or Zepbound.
By Arbor Health Team
For decades, the medical community treated obstructive sleep apnea the same way.
By Arbor Health Team
